RHT resonance health limited
Add to My Watchlist 11.8% ! 3.8¢

News: RHT Resonance Health Signs Patient Access Agreement With Thalassaemia International Federation

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    12/11/21
    12:10
    Post #: 57525743

    Nov 12 (Reuters) - Resonance Health Ltd (RHT) :

    • PATIENT ACCESS AGREEMENT SIGNED WITH THALASSAEMIA INTERNATIONAL FEDERATION
    • SIGNED PATIENT ACCESS TO FERRISMART LOA WITH WORLD HEALTH ORGANIZATION RELATED CYPRUS BASED THALASSAEMIA INTERNATIONAL FEDERATION
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
3.8¢ 		Change
0.004(11.8%) 		Mkt cap ! $17.88M
Open High Low Value Volume
3.5¢ 3.8¢ 3.5¢ $10.85K 298.9K

Buyers (Bids)

No. Vol. Price($)
1 100000 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 160086 1
View Market Depth
Last trade - 15.40pm 18/09/2025 (20 minute delay) ?
RHT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.